Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nymox Pharmaceutical Corp (NASDAQ:NYMX)

2.26
Delayed Data
As of Apr 29
 -0.02 / -0.88%
Today’s Change
1.13
Today|||52-Week Range
4.37
-31.10%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Revenue and IncomeNet Revenues2.6M55.8K46.9K74.7K
 
 
 
 
 
Cost of Goods Sold37.5K34.2K30.7K57.9K
 
 
 
 
 
Depreciation And Amortization1.8K1.4K1.4K1.4K
 
 
 
 
 
 
Operating ExpensesGross Income2.5M20.2K14.7K15.4K
 
 
 
 
 
General Expenses915.6K5.3M10.0M4.0M
 
 
 
 
 
Research And Development557.5K482.7K5.2M2.4M
 
 
 
 
 
Total Operating Expenses954.9K5.3M10.0M4.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income1.6M-5.3M-10.0M-4.0M
 
 
 
 
 
Interest Expense On Debt52.5K56.9K29.7K84.5K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income1.6M-5.3M-10.0M-4.1M
 
 
 
 
 
Net Income1.6M-5.3M-10.0M-4.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS36.3M37.2M39.1M43.0M
 
 
 
 
 
Shares To Calculate EPS Diluted38.3M37.2M39.1M43.0M
 
 
 
 
 
 
Earnings Per ShareEPS$0.04-$0.14-$0.26-$0.10
 
 
 
 
 
EPS Diluted$0.04-$0.14-$0.26-$0.10